⌘K

Login Start Free

Home/Filings/4/0000950170-23-063124

4//SEC Filing

Harmon Seth 4

Accession 0000950170-23-063124

CIK 0001590750other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:17 PM ET

Size

5.6 KB

Accession

0000950170-23-063124

Insider Transaction Report

Form 4

Period: 2023-11-10

Viridian Therapeutics, Inc.\DEVRDN

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2023-11-10+270,000→ 270,000 total
Exercise: $13.76Exp: 2033-11-10→ Common Stock (270,000 underlying)

Footnotes (1)

[F1]The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1

filerCIK 0001993300

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 5:17 PM ET
Size: 5.6 KB

View on SEC.gov